Scott v. Casey

562 F. Supp. 475, 1983 U.S. Dist. LEXIS 17283
CourtDistrict Court, N.D. Georgia
DecidedApril 29, 1983
DocketCiv. A. C81-291A
StatusPublished
Cited by1 cases

This text of 562 F. Supp. 475 (Scott v. Casey) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Scott v. Casey, 562 F. Supp. 475, 1983 U.S. Dist. LEXIS 17283 (N.D. Ga. 1983).

Opinion

ORDER

RICHARD C. FREEMAN, District Judge.

Plaintiffs filed this action against the defendants, seeking monetary relief for injuries sustained as a result of their participation in a medical experiment conducted during the late 1950’s at the United States Penitentiary in Atlanta, Georgia. 1 On February 14, 1983, a trial was held on the limited question whether the plaintiffs’ claims are barred under the two-year or six-month statute of limitations of the Federal Tort Claims Act (hereinafter “FTCA”), 28 U.S.C. § 2401(b). Upon careful consideration of the evidence, the oral arguments presented by counsel at the trial, and the parties’ proposed findings of fact and conclusions of law, the court makes the following findings of fact and conclusions of law. See Rule 52, Fed.R.Civ.P.

I. FINDINGS OF FACT

Between 1955 and 1961, the Central Intelligence Agency (hereinafter “CIA”) of the United States Government conducted an “umbrella project” known as Project MKULTRA, under which various subprojects were funded. MKULTRA was “concerned with the research and development of chemical, biological, and radiological materials capable of employment in clandestine operations to control human behavior.” 2 While MKULTRA was underway, the CIA contacted Dr. Carl C. Pfeiffer, who was then Chairman of the Department of Pharmacology at Emory University School of Medicine in Atlanta, Georgia, concerning a proposed study of lysergic acid diethylamide (hereinafter “LSD”) and its antidotes. Subsequently, Dr. Pfeiffer contacted the United States Bureau of Prisons to request permission to conduct the study under the auspices of the United States Public Health Service (hereinafter “PHS”) and Emory University at the United States Penitentiary in Atlanta, Georgia. 3 Permission was granted and, in 1956, the study commenced. 4

Prior to acceptance into the study, prison applicants were interviewed by the prison psychologist, Dr. L. Bryan. A consent agreement was read to each participant by a medical staff person 5 which stated:

*477 CONTRACT BETWEEN DEPARTMENT OF PHARMACOLOGY, EMORY UNIVERSITY SCHOOL OF MEDICINE and HUMAN VOLUNTEERS AT U.S. PENITENTIARY, ATLANTA, GEORGIA

Date_

I,_, the undersigned applicant, hereby apply for permission to participate in an investigation designed to study the hallucinatory effect of lysergic acid diethylamide, LSD-25, and similar compounds which is being conducted by Emory University School of Medicine in cooperation with the Bureau of Prisons of the Department of Justice. I understand that I will be required to undergo a physical examination, including laboratory tests, in order to ascertain if I am a suitable candidate. I further agree to take the drugs offered me on the day of the experiment. The procedure, the potential benefits to humanity, and the risk to my health of participation in this study have been explained to me by Dr. -, and I understand that there can be no guarantee that I will not become ill as a result of this experiment. I hereby freely assume all such risks of participation in the investigation.

I further agree to cooperate to the fullest extent with the personnel conducting the investigation during the experimental period. I understand that upon completion of my participation in this experiment, the fact that I have thus voluntarily rendered outstanding service to humanity will be placed in my official record. In addition, I understand that each time I am used as a subject, a sum of $3.00 will be deposited in my trust fund account. No such deposit will be made until the Medical Officer has certified that my participation has been satisfactory.

In consideration of the money referred to above, the other considerations referred to above, and for other good and valuable consideration, receipt of which in full is hereby acknowledged by me, I, acting for myself, my heirs, personal representatives, my estate and my assigns, do hereby release Emory University, the doctors, physicians, their assistants and all others participating in this experimental program from all liability of any kind or character, including claims and suits in law or in equity for damages, injury or death which may result to me or to my property from my participation in this experimental investigation.

In witness whereof I hereunto set my hand and affix my seal this the_day of_, 19--

SIGNATURE OF INMATE APPLICANT

Defendants’ Exh. 9. The agreement was signed by each participant. 6 Upon acceptance into the study, each participant was initially given varying oral dosages of LSD and other drugs. Each participant was informed of the dosage level in order to acquaint the participant with the effects of the drugs. If the participant chose to proceed, he reported on a weekly basis for an experimental session which lasted approximately twenty-four hours. Each participant was given varying oral dosages of *478 LSD or other drugs and then observed and tested by medical researchers. The objective signs of drug effect were measured and recorded by one of the physicians participating in the study, who, among other things, took hourly measurements of blood pressure, pulse rate, pupil diameter, oral temperature, and hand steadiness. The subjective mental effects were assayed on the basis of an interview with each participant. At the conclusion of a session, the participant was offered a stipend of $3.00 per session, good-time credit, and a promise of a favorable recommendation to the United States Parole Commission.

Plaintiff Scott became a participant in late 1957. At that time, he knew the study involved the ingestion of LSD and other drugs. Scott testified that he signed a consent form prior to his participation in the study. He stated, however, that he did not sign the form that was identified by the government’s witnesses, Drs. Pfeiffer and Murphree, as the form used in the study. Scott remained in the study until late 1958, at which time he voluntarily left because he was told by a prison staff person that “there was more to it [LSD] than meets the eye.” During and after the study, Scott experienced hallucinations and flashbacks.

Scott testified that he did not learn of the government’s involvement in the study until 1977 when he was shown the book In Search of the Manchurian Candidate by jailhouse lawyer James Miller. Upon cross-examination, Scott was confronted with a copy of In Search of the Manchurian Candidate and admitted that the book was not published until 1979. This inconsistency serves to discredit generally Scott’s testimony.

Plaintiff Knight became a participant in September 1958. At that time, he was informed that he would be ingesting LSD and other drugs. He testified that he underwent an initial trial period in the study.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ritchie v. United States
210 F. Supp. 2d 1120 (N.D. California, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
562 F. Supp. 475, 1983 U.S. Dist. LEXIS 17283, Counsel Stack Legal Research, https://law.counselstack.com/opinion/scott-v-casey-gand-1983.